Novavax (NVAX) Gains Over 46% In 5 Days, To Report Phase 3 NanoFlu Data In Q1

Shares of Novavax Inc. (NVAX) have gained more than 46% over the last 5 trading days, thanks to positive development related to its NanoFlu vaccine.

from RTT - Biotech https://ift.tt/36cwlK9
via IFTTT